FDA to discuss renewal of modified risk orders for Philip Morris products

View organization page for FDA

858,652 followers

FDA has issued a Federal Register notice announcing a Tobacco Products Scientific Advisory Committee (TPSAC) meeting on October 7, 2025. https://xmrrwallet.com/cmx.plnkd.in/eb4fqt_6 The meeting will discuss the renewal of modified risk granted orders issued to Philip Morris Products S.A. for the following products: ➡️ Marlboro Amber HeatSticks  ➡️ Marlboro Green Menthol HeatSticks  ➡️ Marlboro Blue Menthol HeatSticks ➡️ IQOS 2.4 System Holder and Charger ➡️ IQOS 3.0 System Holder and Charger The TPSAC meeting will be open to the public and held at FDA’s White Oak Campus in Silver Spring, MD. Additionally, the public can attend via webcast, and it will be captioned and recorded. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.

  • Image of a panel sitting at a long table with a moderator standing to the right all facing an audience. The title; Tobacco Products Scientific Advisory Committee (TPSAC) Meeting is written with the HHS and FDA logos on the bottom right corner.
Syeda Fatima Unnisa

Ph.D. Candidate in Maths | Author & Educator | Researcher: Cognitive Science • Al • Pedagogy I Science Communicator | Advocate for Ethical & Inclusive STEM

1w

Whenever I see or hear the word 'tobacco’, I can't help but think back to the 1950s controversy, when early studies first linked smoking to lung cancer and the industry responded with aggressive PR and lobbying campaigns. That history always comes to mind when I see modern regulatory discussions like this one. Later, the Chantix to Champix controversies…first over neuropsychiatric side effects and more recently over product recalls due to impurities showed how even smoking cessation tools can face major challenges. Hope that we are learning from that history and moving toward a healthier future.

Like
Reply

To view or add a comment, sign in

Explore topics